To view this email as a web page, click here.
 
Gene therapy drug for blindness carries hefty price tag
A patient advocacy group criticized the hefty price tag of a new treatment for blindness.
Read more
 
Survey uncovers lupus corticosteroid treatment issues
Patients with systemic lupus erythematosus (SLE) often self-manage their corticosteroid medication without the consent of their healthcare providers, according to a recent multicountry survey.
Read more
 
Top 3 new drug approvals
Find out 3 of top new drug approvals.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.